Patents by Inventor Zhong Zuo

Zhong Zuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases
    Patent number: 10570177
    Abstract: Herein provided are peptide inhibitors and methods for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: February 25, 2020
    Assignees: The Chinese University of Hong Kong, University of Copenhagen
    Inventors: Ho Yin Edwin Chan, Knud J. Jensen, Jacky Chi Ki Ngo, Kasper K Sorensen, Qian Zhang, Zhong Zuo
  • P3 PEPTIDYLIC INHIBITORS FOR TREATING CAG-REPEAT RNA TOXICITY IN POLYGLUTAMINE DISEASES
    Publication number: 20180251493
    Abstract: The present invention provides for novel peptide inhibitors and methods for treating polyglutamine (polyQ) diseases. Also disclosed are related compositions and kits for therapeutic use in the treatment of polyQ diseases.
    Type: Application
    Filed: February 13, 2018
    Publication date: September 6, 2018
    Inventors: Ho Yin Edwin CHAN, Knud J. Jensen, Jacky Chi Ki Ngo, Kasper K. Sorensen, Qian Zhang, Zhong Zuo
  • Method of enhancing absorptions of transmucosal administration formulations
    Publication number: 20060051413
    Abstract: Disclosed is a method for enhancing absorption of a medicament that is suitable for administering transmucosally to a subject by providing an environment of the administration with a suitable pH. A medicament of propranolol suitably administered sublingually is provided. The medicament of propranolol can be used for treating cardiovascular diseases.
    Type: Application
    Filed: September 8, 2004
    Publication date: March 9, 2006
    Inventors: Sing Chow, Yan-feng Wang, Zhong Zuo
  • Method of enhancing absorptions of transmucosal administration formulations
    Publication number: 20060051415
    Abstract: Disclosed is a method for enhancing absorption of a medicament that is suitable for administering transmucosally to a subject by providing an environment of the administration with a suitable pH. A medicament of propranolol suitably administered sublingually is provided. The medicament of propranolol can be used for treating diseases related to the cardiovascular system.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 9, 2006
    Inventors: Sing Sum Chow, Yan-feng Wang, Zhong Zuo